send mail to support@abhimanu.com mentioning your email id and mobileno registered with us! if details not recieved
Resend Opt after 60 Sec.
By Loging in you agree to Terms of Services and Privacy Policy
Claim your free MCQ
Please specify
Sorry for the inconvenience but we’re performing some maintenance at the moment. Website can be slow during this phase..
Please verify your mobile number
Login not allowed, Please logout from existing browser
Please update your name
Subscribe to Notifications
Stay updated with the latest Current affairs and other important updates regarding video Lectures, Test Schedules, live sessions etc..
Your Free user account at abhipedia has been created.
Remember, success is a journey, not a destination. Stay motivated and keep moving forward!
Refer & Earn
Enquire Now
My Abhipedia Earning
Kindly Login to view your earning
Support
Context: According to the World Health Organisation WHO Egypt became the first country to achieve “gold tier” status on the path to elimination of hepatitis C as per the global health body criteria.
It includes meeting specific criteria such as
Ensuring 100% blood and injection safety, maintaining a minimum of 150 needles/syringes per year for people who inject drugs (PWID)
Diagnosis of over 80% of people living with chronic hepatitis C virus (HCV),
Treating of over 70% of individuals diagnosed with HCV.
The establishing of a sentinel surveillance Programme for hepatitis sequelae, including liver cancer.
Stringent Criteria: To reach the “gold tier,” Egypt fulfilled specific criteria, including ensuring 100% blood and injection safety, providing a minimum of 150 needles/syringes annually for people who inject drugs, diagnosing over 80% of individuals with chronic hepatitis C virus (HCV), treating over 70% of diagnosed HCV patients, and establishing a surveillance program for hepatitis sequelae, including liver cancer.
Exemplary Results: Egypt has diagnosed 87% of its hepatitis C patients and provided curative treatment to 93% of those diagnosed, surpassing the WHO’s gold tier targets.
“100 Million Healthy Lives” Initiative: Egypt’s ambitious initiative led to a substantial reduction in hepatitis C prevalence, from 10% in 2016 to 5% in 2018 and an estimated less than 1% in 2019, as reported by the Africa CDC.
Leadership Role: Egypt extends support to other African countries, aiming to replicate its success in hepatitis C elimination, including enhancing access to affordable treatment.
It is a viral infection that affects the liver.
It can cause both acute (short term) and chronic (long term) illness. It can be life-threatening.
It is spread through contact with infected blood.
This can happen through sharing needles or syringes, or from unsafe medical procedures such as blood transfusions with unscreened blood products.
It can be passed from an infected mother to her baby and via sexual practices that lead to exposure to blood.
Hepatitis C is not spread through breast milk, food, water or casual contact such as hugging, kissing and sharing food or drinks with an infected person.
Symptoms: It can include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine and yellowing of the skin or eyes (jaundice).
This virus infection occurs in all WHO regions.
The highest burden of disease is in the Eastern Mediterranean Region and European Region.
New HCV infections are usually asymptomatic, few people are diagnosed when the infection is recent.
In those people who develop chronic HCV infection, the infection is often undiagnosed because it remains asymptomatic until decades after infection when symptoms develop secondary to serious liver damage.
There is no vaccine for hepatitis C, but it can be treated with antiviral medications.
By: Shubham Tiwari ProfileResourcesReport error
Access to prime resources
New Courses